Publications on Post-Covid Mucormycosis: A Bibliometric Study of WHO Database.

Authors

  • Paras Sharma Department of Pharmacognosy, BVM College of Pharmacy, Gwalior, India
  • Gargee Dubey Drug Information Retrieval Group, Society for Applied Research in Drug Discovery, Gwalior, India

DOI:

https://doi.org/10.3329/bjms.v20i5.55415

Keywords:

a

Abstract

Background: The COVID-19 pandemic has triggered a large number of publications to inform, understand, conduct more research and control the situation. Although the researchers are analyzing the bibliometrics on this condition, no bibliometric studies are available on the publications related to post-covid mucormycosis. This study is aimed at bibliometric assessment of the publications related to post-covid mucormycosis.

Methods: In the presented study, authors have performed the bibliometric analysis of the World health organization (WHO) database named ‘Global literature on coronavirus disease.’ WHO is maintaining this database since the pandemic, and it contains thousands of reports. Two simple search terms, ‘Covid’ and ‘mucormycosis’ used to search the entire database in ‘title, abstract, subject’ mode with the search string was tw:(mucormycosis covid). The search was not restricted to any date range.

Results: Only 51 reports (40 articles and 01 clinical trials) were obtained with the above search terms. The study found that there is considerable growth in such publication in the last 6 months. Interestingly only three such reports were published in the year 2020. Database wise 38 of these 51 reports were available in Medline. Most of such reports were published by Indian authors. Indian Journal of Ophthalmology emerged as the most productive journal contributing the highest number (10) of these reports.

Conclusions: The highly acclaimed publications were the reviews. This study suggests that India is the most productive country for publications related to post-covid mucormycosis. This resembles the fact that the country, faced the excessive emergence of post-covid-19 mucormycosis cases reported the secondhighest number of Covid 19 cases in the substantial worldwide outbreak in the second wave, which is followed by post covid mucormycosis.

Bangladesh Journal of Medical Science Vol.20(5) 2021 p.144-147

Downloads

Download data is not yet available.
Abstract
1
PDF
9

Downloads

Published

2021-09-05

How to Cite

Sharma, P. ., & Dubey, G. (2021). Publications on Post-Covid Mucormycosis: A Bibliometric Study of WHO Database. Bangladesh Journal of Medical Science, 20(5), 144–147. https://doi.org/10.3329/bjms.v20i5.55415

Issue

Vol 20: 'Special issue on Covid 19' 2021

Section

Original Articles

License

Copyright (c) 2021 Paras Sharma, Gargee Dubey

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.